The Board remands the matter for a medical opinion to determine if the Veteran's acute myelogenous leukemia was related to his service, including potential exposures to benzene and Agent Orange.
The deciding factor: A remand is required due to an error in satisfying a regulatory duty under 20.802(a) by not obtaining a TERA opinion regarding the Veteran's AML.
- Claimed conditions
- Acute myelogenous leukemia (AML)
- How they argued it
- Not specified
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- December 2, 2025
- Citation
- A25103596
Veterans Law Judge
Decisions by this judge: 1,934 · Granted: 41% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25103596.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board has granted the appeals to sever service connection for bladder cancer, acute myelogenous leukemia (AML), and a dental condition secondary to AML. The reasons given are that there was no clear and unmistakable error in granting these conditions of service connection.
- Granted
The Board granted service connection for the cause of the Veteran's death, for purposes of receiving DIC, based on a finding that his AML was related to in-service herbicide exposure and contributed substantially to his death.
- Remanded (sent back)
The Board remands the claim for service connection for cause of death due to acute myelogenous leukemia, as there are outstanding private treatment records and an inadequate VA medical opinion.
- Partly granted
The Veteran was granted a 100 percent rating for acute myelogenous leukemia (AML) from January 22, 2016, to October 31, 2017, and a noncompensable rating from November 1, 2017. The Veteran's earlier effective dates for the grants of service connection for hemorrhoids, anal fissures, pruritus ani, skin disability, and eye disability were also granted.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.